Clinical Trials in Texas

Showing 5061-5080 of 15,101 trials

Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.

NCT05932732

This is a phase IV, unblinded, open-label study assessing the impact on skin quality, hydration, and barrier of three (3) Hydrafacial treatments in healthy adults of Fitzpatrick Skin Types I \& II, III, IV, V \& VI, 30 to 55 years of age. Efficacy and subject satisfaction will be assessed, before and after three (3) HF treatments, in 6 patient cohorts, each cohort defined by FST I-VI.

Cutis Laxa FacialisXeroderma

Austin Institute for Clinical Research27 participantsStarted Nov 2023

Houston, Texas, United States • Pflugerville, Texas, United States

TERMINATEDPhase 355 miles

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

NCT01940900

The objectives of this study are to evaluate the safety and efficacy of intravitreal administration of Fovista® administered in combination with Lucentis® compared to Lucentis® monotherapy in subjects with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD).

Age-Related Macular Degeneration

Ophthotech Corporation627 participantsStarted Aug 2013

Tucson, Arizona, United States • Tucson, Arizona, United States • Fresno, California, United States +118 more locations

Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Find Trials by Condition in Texas

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Clareon Toric vs Eyhance Toric

Vertebral Marrow Attention Trial (VMAT)

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

Transanal Resection of Rectal Lesions With the ColubrisMX ELS System

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil

A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms